Romania: Morphosis Capital buy majority stake in Medima Health

Romanian private equity firm Morphosis Capital announced on Tuesday that it has bought a majority share in Bucharest-based medical health clinic chain Medima Health for an undisclosed sum.

They hope the investment will fuel the expansion of their medical services throughout Romania and also help them fund teleradiology services.

Medima Health co-shareholder and chief medical officer Gheorghe Iana said: "I believe that the partnership with Morphosis Capital paves the way for an increase in the quality of services provided by Medima and it will allow for an expansion of the range of services, in line with the advanced technological progress in Europe."

The venture will be handled by Medima co-shareholder Vlad Ardeleanu.

This is the second such investment for Morphosis Capital, who invest anywhere between €5-10 million per transaction into high-growth Romanian SMEs who have the potential to expand their business internationally. This comes as their first foray into medical health as well as the first company in which they hold a majority stake.

Morphosis Capital managing partner Andrei Gemeneanu said: "We have ambitious goals for turning Medima Health into a regional hub for the second opinion clinic in the radiology niche."

Founded in 2018 by four entrepreneurs, Medima currently has roughly €50 million in committed capital, with the European Investment Fund (EIF), co-financed through the Regional Operational Programme being their primary investors, while various local entrepreneurs are co-investors in the scheme.

The other investment on their portfolio is in digital solutions startup DocProcess.

Medima Health specialises in MRI and CT scanning, oncological diagnostics and teleradiology which currently operate two clinics in Bucharest.

Back to Homepage

Back to Healthcare